https://doi.org/10.4081/monaldi.2021.1607

Uncontrolled diabetes mellitus: A risk factor for post COVID fibrosis

Vol. 91 No. 1 (2021)
Submitted: September 14, 2020
Accepted: November 25, 2020
Published: January 25, 2021
Pulmonary fibrosis, risk factors, infection
Abstract Views: 1669
PDF: 1363
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Parul Mrigpuri
parul57_mrigpuri@yahoo.com
https://orcid.org/0000-0001-7723-4866
Department of Pulmonary Medicine, Vallabhbhai Patel Chest Institute, University of New Delhi, India.
Sonal Sonal
Department of Pulmonary Medicine, Vallabhbhai Patel Chest Institute, University of New Delhi, India.
Sonam Spalgais
https://orcid.org/0000-0001-7116-2486
Department of Pulmonary Medicine, Vallabhbhai Patel Chest Institute, University of New Delhi, India.
Nitin Goel
https://orcid.org/0000-0001-5155-8985
Department of Pulmonary Medicine, Vallabhbhai Patel Chest Institute, University of New Delhi, India.
Balakrishnan Menon
Department of Pulmonary Medicine, Vallabhbhai Patel Chest Institute, University of New Delhi, India.
Raj Kumar
Department of Pulmonary Medicine, Vallabhbhai Patel Chest Institute, University of New Delhi, India.

Dear Editor,

The Corona virus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in the Wuhan province of china in December 2019. COVID-19 spread to the world in a short time and was declared as public health emergency of international concern by World Health Organization...

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med 2020;8:807-15.
Hussain A, Bhowmik B, do Vale Moreira NC. COVID-19 and diabetes: Knowledge in progress. Diabetes Res Clin Pract 2020;162:108142.
Fraser E. Long term respiratory complications of Covid-19. BMJ 2020;370:m3001.
Vasarmidi E, Tsitoura E, Spandidos DA, et al. Pulmonary fibrosis in the aftermath of the COVID-19 era (Review). Exp Ther Med 2020;20:2557-60.
Ojo AS, Balogun SA, Williams OT, Ojo OS. Pulmonary fibrosis in COVID-19 survivors: Predictive factors and risk reduction strategies. Pulm Med 2020;2020:1-10.

How to Cite

Mrigpuri, Parul, Sonal Sonal, Sonam Spalgais, Nitin Goel, Balakrishnan Menon, and Raj Kumar. 2021. “Uncontrolled Diabetes Mellitus: A Risk Factor for Post COVID Fibrosis”. Monaldi Archives for Chest Disease 91 (1). https://doi.org/10.4081/monaldi.2021.1607.
Copyright (c) 2021 The Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.